Essential Tremor: A Neurodegenerative Disease? by Benito-León, Julián
Reviews
Essential Tremor: A Neurodegenerative Disease?
Julia´n Benito-Leo´n
1,2,3*
1Department of Neurology, University Hospital ‘‘12 de Octubre’’, Madrid, Spain, 2Centro de Investigacio´n Biome´dica en Red sobre Enfermedades
Neurodegenerativas (CIBERNED), Madrid, Spain, 3Department of Medicine, Complutense University, Madrid, Spain
Abstract
Background: Essential tremor (ET) is one of the most common neurological disorders among adults, and is the most common of the many tremor disorders. It has
classically been viewed as a benign monosymptomatic condition, yet over the past decade, a growing body of evidence indicates that ET is a progressive condition
that is clinically heterogeneous, as it may be associated with a spectrum of clinical features, with both motor and non-motor elements. In this review, I will describe
the most significant emerging milestones in research which, when taken together, suggest that ET is a neurodegenerative condition.
Methods: A PubMed search conducted in June 2014 crossing the terms ‘‘essential tremor’’ (ET) and ‘‘neurodegenerative’’ yielded 122 entries, 20 of which
included the term ‘‘neurodegenerative’’ in the article title. This was supplemented by articles in the author’s files that pertained to this topic.
Results/Discussion: There is an open and active dialogue in the medical community as to whether ET is a neurodegenerative disease, with considerable evidence
in favor of this. Specifically, ET is a progressive disorder of aging associated with neuronal loss (reduction in Purkinje cells) as well as other post-mortem changes that
occur in traditional neurodegenerative disorders. Along with this, advanced neuroimaging techniques are now demonstrating distinct structural changes, several of
which are consistent with neuronal loss, in patients with ET. However, further longitudinal clinical and neuroimaging longitudinal studies to assess progression are
required.
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Introduction
Neurodegenerative diseases are chronic, progressive disorders of the
nervous system, often of long duration, with loss of specific vulnerable
neuronal populations in the central and peripheral nervous system due
to intrinsic processes rather than an identifiable outside influence (e.g.,
vascular, autoimmune), and they are often associated with gliosis and
typical cytoskeletal protein aggregates.1
Essential tremor (ET) is one of the most common neurological
disorders among adults, and is the most common of the many tremor
disorders.2,3 ET is a widespread condition, affecting people of all races
and cultures, from the remote Eastern Highlands of Papua, New
Guinea, to the urban area of Madrid, Spain (NEDICES study, a
population-based study).4–6 Its most recognizable clinical feature is an
8–12 Hz kinetic tremor of the arms (i.e., tremor during voluntary
movement), which often is later accompanied by head and voice
tremors.7–10 The traditional view of ET as a monosymptomatic
condition is being replaced as a spectrum of clinical features, with both
motor and non-motor elements, including ataxia, parkinsonism,
cognitive impairment, dementia, personality disturbances, depressive
symptoms, sensory abnormalities (e.g., mild olfactory dysfunction and
hearing impairment), dysfunction of the upper respiratory airways,
voice disturbances, and sleep disorders increasingly being documen-
ted.11–25 Furthermore, recent histopathological and neuroimaging
studies in ET have demonstrated several distinctive structural changes,
including neuronal loss.26–28
With increasing data emerging from these new clinical, neuroima-
ging, and pathological studies, a crucial question arises. Is ET
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neurodegenerative? The idea that ET could be neurodegenerative is
not novel. In the landmark paper by Critchley and Greenfield,
published in 1948, the authors wrote: ‘‘Although anatomical proof is as
yet lacking, there are at least a number of clinical points to make
question whether ‘‘essential tremor’’ may not, at times any rate,
represent an incomplete or a premature variant of one of the cerebellar
atrophies.’’29 Although not further elaborated on by those authors,
these clinical characteristics include its insidious onset, association with
advanced aging (i.e., both prevalence and incidence rates increase with
age), gradually progressive nature, and the presence of ‘‘cerebellar’’
features (e.g., intention tremor and ataxia) on examination.29 Indeed,
these are many clinical features typical of neurodegenerative diseases
of the cerebellum.
In this review, I will discuss the most significant milestones in ET
research, which, when taken together, suggest that ET is a
neurodegenerative condition.
Methods
A PubMed search conducted in June 2014 crossing the terms
‘‘essential tremor’’ (ET) and ‘‘neurodegenerative’’ yielded 122 entries,
20 of which included the term ‘‘neurodegenerative’’ in the article title.
This was supplemented by articles in the author’s files that pertained to
this topic. Of note is that a recent review of the 100 most cited papers
on ET revealed that none dealt with issues related to neurodegenera-
tion.30
Alternative hypothesis on central oscillating pacemakers
The traditional hypothesis about pathogenesis of ET, since the early
1970s, posited the existence of a central tremor pacemaker or oscillator
(the olivary model).31 A theoretical disturbance in the inferior olivary
nucleus, an anatomic structure with inherent oscillatory pacemaking
properties, was thought to be the possible origin of ET.32 This
hypothesis was based on three observations. First, the original post-
mortem examinations in ET erroneously concluded that there were no
relevant pathological changes.28 Many of these examinations were
published 50–100 years ago, and few described relevant brain
structures in detail.9 A further problem was the absence of any age-
matched control brains for comparison.9 Second, there is an animal
model of tremor using the neurotoxin harmaline, a potent tremor-
producing chemical that is present in the human diet, especially in
animal proteins (meats) that are cooked at high temperatures for
extended periods.33–35 This neurotoxin causes non-specific action
tremor in laboratory animals and post-mortem changes in the
olivocerebellar pathway in these laboratory animals.33–35 Harmaline
may excite inferior olivary neurons, causing marked Purkinje cell
destruction.36 However, action tremor is a non-specific sign.7–10
Further, the harmaline model is not a model of the human disease but
an animal toxin model of acute tremor,37 since it causes tremor, which
tends to resolve after a few hours.37 Third, in the inferior olivary
nucleus there are cells with pacemaking properties;35,38 in other words,
they can fire in a coordinated and rhythmical fashion.37 However, the
model is merely conjectural;37 there is no empiric evidence that the
olivary model is an accurate reflection of what is occurring in human
beings with ET.37 In addition, the inferior olivary nucleus is not the
only anatomic region in the central nervous system with pacemaker
properties; there are many more examples of pacemakers in the central
nervous system, including those in the locus ceruleus,39 the dorsal
raphe nucleus,40 the thalamus,41 and the Purkinje cells from the
cerebellum.42 Thus, one wonders why the inferior olivary nucleus and
not any of the above pacemakers has been postulated to be
pathologically relevant in ET.37 Finally, imaging studies have not
demonstrated any consistent changes in the inferior olivary nucleus
and post-mortem studies have not found any structural changes
either.26,43,44
In closing, the lack of empiric evidence as well as the new emerging
data on the neurodegenerative model of ET (as discussed next) have
now called the olivary model into question.45
The neurodegenerative model
Clinical studies
As with other neurodegenerative diseases, such as Parkinson’s
disease (PD) or Alzheimer’s disease (AD),46–49 the incidence of ET
increases with age.50 In a study of a multiethnic community in
northern Manhattan, New York, more than one in five individuals in
the oldest age group (>95 years of age) had this disease.51
ET is a progressive disorder, which worsens over time in most
patients.7–9 Several processes could contribute in the progression of
symptoms in ET, including the inherent worsening of the underlying
disease with increasing disease duration and the effects of aging on the
nervous system, yet there are few prospective studies on ET that have
attempted to identify the variables that influence progression of ET.52–56
Interestingly, disease duration and age are independently associated
with tremor severity in ET.57 This suggests that the reported increase in
tremor severity in ET may be related to the inherent worsening of the
disease with increasing duration, and that this is independent of age and
age-related processes like neuronal attrition and change in tremor
frequency.57 In a large clinical sample, older age of onset was associated
with more rapid tremor progression.58 In a brain bank, older age of
onset was associated with more degenerative pathology in the
cerebellum.58
Only a few longitudinal studies have actually attempted to quantify
the rate of actual tremor progression.52–56 An increase in tremor
amplitude of about 30% in a period of 4 years and a decrease of
frequency by approximately 0.06 to 0.08 Hz/year together with a
reduction in tremor frequencies has been observed by accelerometry
and surface electromyography.55 A few longitudinal data53,56 have
described a small, but significant, increase in tremor severity in ET
patients, estimated as 12% per year from baseline evaluation in one
clinical series,29 and an average annual increase in tremor severity
from baseline between 3.1% and 5.3% in another recent series
followed for >5 years.56
In addition, disease progression is not only characterized by
spreading of tremor to the head (neck), which eventually occurs in
approximately 40% of patients,59 but also by the occurrence of
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abnormalities of cerebellar function in ET.7–9 The wide spectrum of
cerebellar symptoms that may be observed in ET, include the presence
of intentional tremor,7–9,60 gait ataxia,11,38–40 dysarthria,61 oculomotor
abnormalities,62 as well as deficits in hand–eye coordination.63
Specifically, gait disturbances (i.e., ataxia) are seen more frequently
in ET patients with longer disease duration who are at an advanced
stage of ET and among those cases with midline (e.g., cranial)
tremors.11,64–67 Of further interest is the observation that gait
abnormalities in ET can temporarily improve with ethanol intake.68
In one study, the ingestion of ethanol to a mean blood level of 0.45%
led to a transient but significant improvement of ataxia in ET patients
yet produced a worsening of gait parameters in controls.68 Ethanol
binds to the gamma-aminobutyric acid (GABA) receptor, thereby
facilitating GABAergic neurotransmission.7–9 One should bear in
mind that the neurochemical deficit involving ataxia and tremor could
be the same, that is a deficit in GABA cerebellar neurotransmission.7–9
Therefore, tremor and ataxia could respond to an enhancement of
GABAergic neurotransmission.7–9
Rest tremor of the arms is observed in one in five ET patients and
also it may be an early sign of ET.69 In one tertiary referral center, the
patients with rest tremor had kinetic tremor that was more severe,
more disseminated, and of longer duration than ET patients without
rest tremor.69 Although the pathogenesis of rest tremor in ET is
unknown,70 it could be related to pathologic spreading to extracer-
ebellar circuits in patients with severe, long-standing, and disseminated
disease. Alternatively, it may result from a pathological interaction
between the basal ganglia and the cerebello-thalamo-cortical circuits.71
As the heterogeneity of ET becomes more evident, researchers have
expressed increased interest in exploring the possibility that there are
associated findings (e.g., motor and non-motor manifestations)
associated with this disorder, and that it may be associated with other
neurodegenerative diseases (e.g., PD or AD).7–9,72
The weight of emerging evidence is indicating that ET is also
associated with a series of non-motor manifestations, including
cognitive deficits,14,15,73–76 mild cognitive impairment,13 demen-
tia,16,17,77 personality changes,18 depressive symptoms,19 possible mild
olfactory dysfunction,20,78,79 hearing impairment,21,22 and sleep
disorders.80,81 Several of these non-motor manifestations are also seen
in many other neurodegenerative conditions, such as PD and
Huntington’s disease, among others.82,83
As in other neurodegenerative diseases,84,85 cognitive deficits,
mainly in frontal-executive function and memory, have been reported
to occur in ET patients in a range of independent studies,14,15,73–76
including a population-based case–control study of largely treatment-
naive ET patients nested in the NEDICES study.15 Taken together,
these studies indicate that a frontosubcortical-type dysfunction occurs
in some ET patients.14,15,73–76 Overall, the degree of cognitive
impairment in ET is mild and is thought to be due to a dysfunction
in the dorsolateral prefrontal cortex and in the inferior parietal cortex,
including the cerebral–cerebellar loop.86 In the NEDICES study,
baseline cognitive test scores were lower in non-demented ET cases
than non-demented controls;76 moreover, during the 3-year follow-up
period, these scores declined at a rate that was seven-times faster in ET
cases.76
The NEDICES study also provided evidence that cognitive deficits
in premotor ET (that is, ET cases who underwent neuropsychological
evaluations at a baseline visit prior to the onset of their tremor) are not
static, and that they appear to be progressing at a faster rate than in
elders who do not develop this disease.87 In addition, an association
between elderly-onset ET and prevalent mild cognitive impairment
was demonstrated in the NEDICES study.13 In line with this, in the
NEDICES study, elderly-onset ET was found to be associated with
prevalent dementia.16 ET cases with tremor onset after 65 years of age
were 70% more likely to have dementia than were similarly aged
controls.16 In the follow-up of the same population, ET cases with
tremor onset after age 65 years were twice as likely to develop incident
dementia than were controls, whereas ET cases with tremor onset,65
years of age and controls were equally to develop incident dementia.17
In a second population-based study of elders in New York, ET was also
associated with both increased odds of prevalent dementia and
increased risk of incident dementia,77 with odds ratios and relative risks
similar to those reported in the NEDICES study.77 In both studies, the
large majority of subjects with dementia had AD.16,77 Although
additional studies are needed, these two studies suggest that the
presence of dementia in ET appears to be greater than expected for
age and that there are links between ET and AD.16,77 In a recent study
that included 40 ET patients who were free of dementia clinically and
without AD on post-mortem examination and 32 age-matched
controls, ET patients had a higher Braak neurofibrillary stage, but
similar scores for neuritic plaques.88 ET may predispose individuals to
accumulate more widespread cellular tau aggregates, and thus tau
could play a central role in the cognitive impairment that can
accompany ET.88
The relationship between ET and PD has been a subject of reviews
and debate for a long time, but there is now growing evidence that the
two disorders are related, at least in some patient populations.12,89–92
Clinical series, follow-up studies of ET patients, and case–control and
genetic epidemiological studies indicate that ET is associated with
increased risk for PD.89 In addition, some neuroimaging studies and
neuropathological reports suggest an association between the two
diseases. Some ET patients may have a circumscribed form of Lewy
body disease, and the secondary development of PD may represent a
spread of those Lewy bodies in the brainstem.91 ET patients may have
some degree of bradykinesia. In a recent study, ET patients showed
impaired motor performance, at least in some tasks, such as rapid
repetitive finger movements (finger tapping and frequency) and visual
reaction time (impairment was not related with tremor severity).93 The
link between ET and PD has been formally quantified in the
NEDICES study, which demonstrated that the risk of developing
incident PD was 4.3 times higher in ET cases than in age-matched
controls without ET.12
Depressive symptoms might be more prevalent in ET than in the
population,19 as is seen in other neurodegenerative diseases, such as
PD.94 In the NEDICES study, prevalent ET cases were twice as likely
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as controls to report depression and three times more likely to be
taking antidepressant medications.19 In prospective analyses of this
study, baseline self-reported depression was associated with incident
ET.19 These prospective data suggest that the mood disorder in ET
may be more than a secondary response to disease manifestations; this
mood disorder may be a primary feature of the underlying disease.19
Mild olfactory dysfunction has been detected in ET patients in
several studies,20,95 but not in others;78,96 when observed, this
dysfunction is, on average, milder than that observed in patients with
PD.20,95 As in PD, this possible dysfunction does not correlate with
disease duration or severity, indicating that it occurs early in the
disease process.20
Hearing impairment in ET has been reported in two case–control
studies.21,22 At a tertiary referral center, ET was associated with
hearing impairment, as shown by both subjective and objective
measures of hearing loss.21 Similarly, in the NEDICES study, ET
patients reported more hearing impairment than did matched
controls.22 The basis for this possible hearing impairment is unknown.
However, both central and peripheral nervous system mechanisms
have been suggested.21
Sleep dysregulation is often described in neurodegenerative
diseases.97,98 The association between sleep dysregulation and ET
has been assessed in several studies.80,99 Adler et al.99 compared
Epworth Sleepiness Scale scores (ESS) in 53 ET cases to 49 PD cases
and 175 normal controls, and noted no ET case–control difference; in
that study, ESS scores in ET were intermediate between normal
controls and PD but far more similar to those of normal controls.99
Chandran et al.80 found a marked difference in Pittsburgh Sleep
Quality Index (PSQI) scores in 50 ET cases as compared with 50
controls, yet no difference in ESS scores. Gerbin et al.81 compared the
ESS and the PSQI scores in 120 ET cases, 120 normal controls, and
40 PD cases. The ET case–control difference was not significant, yet in
a test for trend, PD cases had the highest PSQI score, followed by ET
(intermediate), and lowest scores in controls. Finally, in NEDICES
short sleep duration was associated with an increased risk of ET.25
Similar to PD and AD, the two paradigmatic neurodegenerative
diseases, there is a proportion of the ET patients with a clear family
history of disease, which is lower in PD and AD, and higher in ET.100
The risk of action tremor and ET is increased in the relatives of PD
patients, particularly when they have tremor-dominant PD.101,102
These findings suggest that PD and ET may share familial
susceptibility factors.90
Pathological evidence
There is a marked and continued rise in ET prevalence and
incidence in advanced ages.7–9 ET has an insidious onset and then
follows a gradual yet progressive clinical course.7–9 The clinical
constellation, discussed in the previous section, is somewhat compel-
ling; however, none of the clinical features in isolation is specific to
neurodegenerative diseases. On a tissue-based level, the evidence is
more compelling.44
A fundamental question about the neurodegenerative nature of a
neurological disorder is whether there are histopathological changes in
the brain. Selective involvement of an anatomically and physiologically
related system of neurons (Purkinje cells), has been reported in ET
cases in recent series.44 Until several years ago, only 25 reported post-
mortem examinations in ET were available, many of which were
published 50–100 years ago, and few of which described relevant brain
structures in detail.9 A further problem was the absence of any age-
matched control brains for comparison. The Essential Tremor
Centralized Brain Repository at Columbia University (New York,
NY) was established in 2003 to prospectively collect and study in detail
the brains of individuals with ET, and to compare them with matched
control brains.103 A preliminary analysis, including 10 ET cases and 12
controls, demonstrated that ET may be pathologically heteroge-
neous.104 The number of torpedoes (a marker of axonal damage or
regenerative process) and Bergmann glia was increased in ET cases;104
six cases (60%) had Lewy bodies vs. two controls (16.7%); four of these
six had an atypical distribution of brainstem Lewy bodies.104 Overall,
ET cases clustered into two groups: those with cerebellar degenerative
changes (n54) and those with brainstem Lewy bodies (‘Lewy body
variant of ET’; n56), raising the possibility that some ET cases have a
form of Lewy body disease.104 Of note, the presence of torpedoes is not
specific to ET, and is observed in other well-known neurodegenerative
conditions, such as progressive supranuclear palsy, dentatorubropalli-
doluysian atrophy,105 and fragile X-associated tremor/ataxia.106
A more relevant study by Axelrad et al.107 demonstrated a reduction
in Purkinje cell number in the brains of patients with ET who did not
have Lewy bodies. These data further support the view that the
cerebellum is anatomically, as well as functionally, abnormal in these
ET cases.107 Recently, an abundance of torpedoes has been shown in
the cerebellar vermis of ET brains, mainly in patients with neck, voice,
and jaw tremors.108
In the Essential Tremor Centralized Brain Repository of New York,
which compared 33 ET cases to 21 controls, the mean number of
Purkinje cells per 1006 field was reduced in ET cases and there were
approximately seven times as many torpedoes in ET cases as well.109
Two cases also had degeneration of the dentate nucleus.109 Other
structural abnormalities in ET cases were Purkinje cell heterotopias
and Purkinje cell dendrite swellings as well as hypertrophy of basket
cell axonal processes.109,110 Eight (24.2%) of the 33 ET brains had
Lewy bodies in the brainstem, mainly in the locus ceruleus, and
normal cerebella.109 By contrast, two recent studies reported no
reduction in Purkinje cells in ET111 or have concluded that there is no
clear distinction between ET, PD, and normal control subjects in the
number of Purkinje cells.112 However, there are a number of
significant methodological problems with the design of these studies,
and these issues cast considerable doubt on the validity of the reported
results.113
In summary, clearly identifiable structural changes (i.e., Purkinje cell
loss, Lewy bodies) have been observed in the brains of ET patients.28
These changes are not uniform and seem to follow several patterns,
localizing to the cerebellum itself or to a collection of brainstem
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neurons in the locus ceruleus that synapse directly with Purkinje
cells.28 Furthermore, these changes are similar to those seen in
degenerative diseases.28
Neuroimaging evidence
In contrast to post-mortem studies, neuroimaging studies provide
a non-invasive method to examine structural changes in living
patients who have not yet arrived at an end-stage of disease. A broad
array of neuroimaging methods used in a rising tide of studies,
including functional magnetic resonance imaging (MRI) studies,114
positron emission tomography studies,115,116 [1H] magnetic resonance
spectroscopic imaging studies,117–119 diffusion tensor imaging stu-
dies,120–122 voxel-based morphometry studies,26,123,124 and studies
using other automated volumetric methods,125 now indicate the
presence not only of functional and metabolic abnormalities in the ET
cerebellum, but of structural abnormalities in both the cerebellar gray
and white matter as well.126
A reduction in cerebellar cortical N-acetyl-L-aspartate (NAA) and
total choline, relative to total creatine (tCR), indicates that there is
neuronal damage or loss in ET, suggesting that ET may be a
neurodegenerative disease.117–119 Voxel-based morphometry studies
using 1.5 T MRI have led to contradictory results;123,124 however, by
using 3 T MRI, structural white and gray abnormalities may be
detected in ET patients in both the cerebellum and different cerebral
areas. Specifically, Benito-Leo´n et al.26 detected white matter changes
in several areas (right cerebellum, left medulla, right parietal lobe, and
right limbic lobe) and gray matter changes in several areas as well
(bilateral cerebellum, bilateral parietal lobes, right frontal lobe, and
right insula) in 19 ET patients vs. 20 controls. In line with these
results,26 another recent report of 20 ET patients and 20 controls
showed widespread areas of atrophy in both the cerebellum and
cerebral gray matter, as well as a relationship between gray matter
atrophy and tremor severity score, which supports the current concept
of the progressive and diffuse nature of ET.127
Diffusion-weighted imaging is used to search for evidence of tissue
integrity abnormalities; although a previous study did not detect any
significant changes between 10 ET patients and 10 controls, another
study involving 10 ET patients and eight controls122 showed a
significantly reduced fractional anisotropy in the anterolateral portion
of the right pons and decreased fractional anisotropy in the bilateral
cerebellum, left retrorubral area of the midbrain, and bilateral deep
white matter, including the orbitofrontal, lateral frontal, parietal, and
temporal white matter. Further, by means of 3 T MRI, significant
reduction of fractional anisotropy was reported in the dentate nucleus
and superior cerebellar peduncle of patients with familial ET;121
additionally, among patients with familial ET, those with longer
disease duration showed fractional anisotropy values in the dentate
nucleus lower than those with shorter disease duration. Finally, Klein
et al.,120 by means of a whole-brain analysis with tract-based spatial
statistic, confirmed by voxel-wise analysis, circumscript pathology of
the inferior cerebellar peduncles. Moreover, increased diffusivity in
white matter structures of both hemispheres suggests widespread
alterations of fiber integrity in motor and non-motor networks in ET
patients.120
Finally, in a study using volumetric data obtained with automated
segmentation of subcortical and cerebellar structures, reduction of
cerebellar volume in patients was observed in patients with head
tremor when compared with healthy controls, after controlling for
intracranial volume was observed.125
Conclusions
The neurodegenerative hypothesis of ET on the surface seems at
odds with the early onset and clinically slow and heterogeneous
progression of ET in some patients.128 Indeed, some researchers have
advocated for an alternative pathophysiological explanation for ET
based on central oscillating pacemakers.128 This hypothesis would not
require structural changes in the anatomical organization or
connectivity of the cerebello-thalamo-cortico-cerebellar loops.128
However, the hypothesis is purely conjectural and based on little if
any empiric evidence. ET is a progressive, aging-associated condition,
associated with cell loss (reduction in Purkinje cell number in properly
designed studies) and other types of changes (Lewy body formation)
that traditionally occur in neurodegenerative disorders. Further, the
overwhelming data from different independent study groups, including
new pathological and MRI findings, as well as the constellation of non-
motor findings, all present in the same disease, similar to other
neurodegenerative diseases, suggest that ET is a neurodegenerative
disease.129,130 In addition, the considerable evidence for an association
between ET and PD and the fact that elderly-onset ET increases the
risk of developing AD nearly twofold suggests that ET may share
pathogenic mechanisms with these disorders. Finally, there are no
reported cases of spontaneous remission of ET; a disease condition
whose pathophysiology was based on a disorder of a central oscillating
pacemaker might result in either a spontaneous improvement or
disappearance of the same. However, further longitudinal clinical and
neuroimaging longitudinal studies to assess progression are required.
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